Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

One Tube 23 Color Full Spectral Flow Cytometry Panel in Detecting Minimal Residual Disease in Pediatric B-Cell Acute Lymphoblastic Leukemia

Kefei Wu, Zhen Wang, Yangyang Xie, Xiang Wang, Wenting Hu, Jiaoyang Cai, Lixia Ding, Benshang Li, Shuhong Shen

Blood (2023) 142 (Supplement 1): 1607.

https://doi.org/10.1182/blood-2023-181565

Published: 2023

Journal Articles

3rd-Generation Tyrosine Kinase-Inhibitors and Azacitidine Are Safe and Effective in Myeloid Blast-Phase Chronic Myeloid Leukaemia and Result in a High Proportion of Subjects in 2 nd Chronic Phase Able to Receive a Transplant

Mei Bao, Xiang Wang, Xiao-shuai Zhang, Zong-ru Li, Robert Peter Gale, Xiao-jun Huang, Qian Jiang

Blood (2023) 142 (Supplement 1): 4550.

https://doi.org/10.1182/blood-2023-185346

Published: 2023

Journal Articles

Genomic Landscape of Pediatric Non-Down's Syndrome Acute Megakaryoblastic Leukemia in China

Blood (2023) 142 (Supplement 1): 4331.

https://doi.org/10.1182/blood-2023-181798

Published: 2023

Journal Articles

Distinct Genomic Landscape of Chinese Pediatric Acute Myeloid Leukemia

Ting Liu, MD, Jianan Rao, Master, Wenting Hu, MD, Yuhan Liu, MD, Huiying Sun, Master, Xiaoxiao Chen, MD, Yanjing Tang, MDPhD, Jing Chen, MD, Xiang Wang, PhD, Han Wang, Master, Wubin Qian, PhD, Binchen Mao, PhD, Sheng Guo, PhD, Ronghua Wang, Master, Yu Liu, PhD, Shuhong Shen, MD PhD

Blood (2020) 136 (Supplement 1): 38.

https://doi.org/10.1182/blood-2020-140150

Published: 2020

Journal Articles

Safety and Efficacy Evaluation of 4SCAR19 Chimeric Antigen Receptor-Modified T Cells Targeting B Cell Acute Lymphoblastic Leukemia - Three-Year Follow-up of a Multicenter Phase I/II Study

Lung-Ji Chang, PhD, Lujia Dong, MD, Yu-Chen Liu, MSc, Shih-Ting Tsao, MSc, Ya-Chen Li, PhD, Li Liu, MD, Zhiyong Gao, MD, Xiyou Tan, MD, Dao-Pei Lu, MD, Jian-Ping Zhang, Jing-Bo Wang, Yu-Ming Ying, MD, Le-Ping Zhang, MD, Huyong Zheng, MD PhD, Kai Wang, MD PhD, Xiao-Li Zheng, MD, Heng-Xiang Wang, MD, Xun Lai, MD, Dong Li, MD

Blood (2016) 128 (22): 587.

https://doi.org/10.1182/blood.V128.22.587.587

Published: 2016

Journal Articles

Chimeric Antigen Receptor 4SCAR19-Modified T Cells in Acute Lymphoid Leukemia: a Phase II Multi-Center Clinical Trial in China

Lujia Dong, MD, Lung-Ji Chang, PhD, Zhiyong Gao, MD, Dao-Pei Lu, MD, Jian-Ping Zhang, MD, Jing-Bo Wang, MD, Le-Ping Zhang, MD, Yu-Hong Chen, MD, Hu-Yong Zheng, MD, Ting Liu, Ting Niu, MD PhD, He Huang, MD PhD, Rong Liu, MD, Heng-Xiang Wang, MD, Li Gao, MD, Tong-Hua Yang, MD, Xun Lai, MD

Blood (2015) 126 (23): 3774.

https://doi.org/10.1182/blood.V126.23.3774.3774

Published: 2015

Journal Articles

Could Anthracycline be Replaced in Chemotherapy for Acute Myeloid Leukemia? Randomized Clinical Trial of Homoharringtonine As Frontline Agent to Treat Pediatric AML

Shuhong Shen, MD PhD, Xiang Wang, PhD, JingYan Tang, MD, Huiliang Xue, Jing Chen, Yanjing Tang, MD, Long-Jun Gu, MD

Blood (2014) 124 (21): 975.

https://doi.org/10.1182/blood.V124.21.975.975

Published: 2014

Journal Articles

Prolonged Thrombocytopenia After Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) and Its Association with an Increase in CD8+ CX3CR1+ Cells in Bone Marrow.

Xiao-hui Zhang, MD, PhD, Guo-xiang Wang, MD, Yan-rong Liu, MD, Lan-Ping Xu, MD, Kai-Yan Liu, MD, Wei Han, MD, Yu Wang, MD, Hai-xia Fu, MD, Meng Lv, MD, Min Wang, MD, Yi Zhou, MD, Xiao-Jun Huang, MD

Blood (2012) 120 (21): 3077.

https://doi.org/10.1182/blood.V120.21.3077.3077

Published: 2012

Journal Articles

Cytogenetic and Molecular Features of 1331 Chinese Patients with Primary Acute Lymphoblastic Leukemia (ALL).

Blood (2009) 114 (22): 4718.

https://doi.org/10.1182/blood.V114.22.4718.4718

Published: 2009

Journal Articles

Autophagy as a Target Pathway in Multiple Myeloma: A Forward Chemical Genetic Approach.

John P. Shen, BS, Sanjay Divakaran, Letian Kuai, Ph.D., Xiang Wang, Ph.D., Shao-En Ong, Ph.D., Ravi Amaravadi, M.D., John Wood, Ph.D., Steven Carr, Ph.D., Stuart Schreiber, Ph.D., Stephen Haggarty, Ph.D., James Bradner, M.D.

Blood (2007) 110 (11): 2510.

https://doi.org/10.1182/blood.V110.11.2510.2510

Published: 2007

Journal Articles

A Experimental Study and Clinical Result of Prophylaxis aGVHD with Humanized Anti-CD25 Monoclonal Antibody in Haploidentical BMT.

Shu-Quan Ji, MD, Hui-Ren Chen, MD, Heng-Xiang Wang, Hong-Min Yan, Mei Xue, Jing Liu, Chang-Q.(Micky) Xun, MD

Blood (2004) 104 (11): 1251.

https://doi.org/10.1182/blood.V104.11.1251.1251

Published: 2004

Journal Articles

Haploidentical Bone Marrow Transplantation for Treatment of Patients with Aggressive and Refractory Lymphoma.

Hui-Ren Chen, MD, Shu-Quan Ji, MD, Heng-Xiang Wang, Hong-Min Yan, Mei Xue, Jing Liu, Chang-Q.(Micky) Xun, MD

Blood (2004) 104 (11): 5159.

https://doi.org/10.1182/blood.V104.11.5159.5159

Published: 2004

Journal Articles

Specific homeodomain-DNA interactions are required for HOX11-mediated transformation

Bronwyn M. Owens, Yuan-Xiao Zhu, Ting-Chung Suen, Pei-Xiang Wang, Jack F. Greenblatt, Paul E. Goss, Robert G. Hawley

Blood (2003) 101 (12): 4966–4974.

https://doi.org/10.1182/blood-2002-09-2857

Published: 2003

Journal Articles

Epithelial membrane protein 2, a 4-transmembrane protein that suppresses B-cell lymphoma tumorigenicity

Chun-Xiang Wang, Madhuri Wadehra, Bernard C. Fisk, Lee Goodglick, Jonathan Braun

Blood (2001) 97 (12): 3890–3895.

https://doi.org/10.1182/blood.V97.12.3890

Published: 2001

Journal Articles

Overexpression of murine fizzy-related (fzr) increases natural killer cell–mediated cell death and suppresses tumor growth

Chun-Xiang Wang, Bernard C. Fisk, Madhuri Wadehra, Helen Su, Jonathan Braun

Blood (2000) 96 (1): 259–263.

https://doi.org/10.1182/blood.V96.1.259

Published: 2000

NARROW

One Tube 23 Color Full Spectral Flow Cytometry Panel in Detecting Minimal Residual Disease in Pediatric B-Cell Acute Lymphoblastic Leukemia

3rd-Generation Tyrosine Kinase-Inhibitors and Azacitidine Are Safe and Effective in Myeloid Blast-Phase Chronic Myeloid Leukaemia and Result in a High Proportion of Subjects in 2 nd Chronic Phase Able to Receive a Transplant

Genomic Landscape of Pediatric Non-Down's Syndrome Acute Megakaryoblastic Leukemia in China

Distinct Genomic Landscape of Chinese Pediatric Acute Myeloid Leukemia

Safety and Efficacy Evaluation of 4SCAR19 Chimeric Antigen Receptor-Modified T Cells Targeting B Cell Acute Lymphoblastic Leukemia - Three-Year Follow-up of a Multicenter Phase I/II Study

Chimeric Antigen Receptor 4SCAR19-Modified T Cells in Acute Lymphoid Leukemia: a Phase II Multi-Center Clinical Trial in China

Could Anthracycline be Replaced in Chemotherapy for Acute Myeloid Leukemia? Randomized Clinical Trial of Homoharringtonine As Frontline Agent to Treat Pediatric AML

Prolonged Thrombocytopenia After Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) and Its Association with an Increase in CD8+ CX3CR1+ Cells in Bone Marrow.

Cytogenetic and Molecular Features of 1331 Chinese Patients with Primary Acute Lymphoblastic Leukemia (ALL).

Autophagy as a Target Pathway in Multiple Myeloma: A Forward Chemical Genetic Approach.

A Experimental Study and Clinical Result of Prophylaxis aGVHD with Humanized Anti-CD25 Monoclonal Antibody in Haploidentical BMT.

Haploidentical Bone Marrow Transplantation for Treatment of Patients with Aggressive and Refractory Lymphoma.

Specific homeodomain-DNA interactions are required for HOX11-mediated transformation

Epithelial membrane protein 2, a 4-transmembrane protein that suppresses B-cell lymphoma tumorigenicity

Overexpression of murine fizzy-related (fzr) increases natural killer cell–mediated cell death and suppresses tumor growth

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only